Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | MDGLMadrigal Pharmaceuticals, Inc.FY2025 · Dec |
|---|---|
| Revenue | $958.40M |
| Revenue, yoy | +432.1% |
| Net income | $288.28M |
| Net income, yoy | +38.1% |
| Net margin | -30.1% |
| Free cash flow | $190.02M |
| FCF margin | -19.8% |
| EPS, diluted | $10.15 |
Add another company.